mynth
05/2025

HUBLO acquired by FIVE ARROWS

FRANCE Healthcare Services / Health Tech EV 100M - 350M EUR

Context

Hublo enters a new phase of its development by welcoming Five Arrows as its new lead shareholder. This transaction marks a transition from Venture Capital to Private Equity (Primary LBO). The entry of Five Arrows aims to provide Hublo with the strategic and financial resources to consolidate its leadership in France and accelerate its expansion in Europe, particularly in Germany and Northern Europe. The partnership will focus on product innovation (AI integration for planning) and potential strategic acquisitions to build a comprehensive HR platform for the healthcare sector.

HUBLO, which reported an EBITDA margin of in 2024, is valued in this transaction at an EV/EBITDA multiple of , a level to compare with the average currently observed in the Healthcare & Pharma sector (14.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

A leading European digital platform for healthcare workforce management. Hublo helps hospitals, nursing homes, and clinics manage their internal and external staff replacements efficiently. By automating the recruitment and mobilization process of temporary workers and internal pools, it addresses the critical shortage of healthcare professionals. It serves over 3,500 facilities and 800,000 healthcare professionals in Europe (France and Germany).

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2024
2023

Similar deals in Healthcare Services

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
DateAcquirerTargetCountrySector
11/2025ASKER HEALTHCARE GROUPFINMED GROUPFRANCEHospital Logistics
10/2025EVOLEMAPPERTONFRANCESterilization & Hygiene
04/2025TRANSCARENTACCOLADEUNITED STATESHealth Tech
04/2025KERSIANEOGEN (ANIMAL BIOSECURITY DIVISION)UNITED STATESSterilization & Hygiene
10/2024FullscriptRupa HealthUNITED STATESHealth Tech
07/2024ARDIANMASCO GROUPITALYHealthcare Services
06/2024PERMIRAPHARMACORDUNITED STATESHealth Tech
05/202421 INVEST / OAKLEY CAPITAL INVESTMENTSPRODUCT LIFEFRANCEHealthcare Services
10/2023MOTION EQUITY PARTNERSBANOOKFRANCECRO / Clinical Trials
09/2023PERMIRAERGOMEDUNITED KINGDOMCRO / Clinical Trials

REFERENCES

Valuation range: EV 100M - 350M EUR

Revenue range: 25M - 50M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of HUBLO by FIVE ARROWS are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Target: hublo

Acquirer: five arrows